Unknown

Dataset Information

0

Gabapentin for smoking cessation.


ABSTRACT: We conducted a preliminary proof-of-concept study evaluating gabapentin for the treatment of tobacco dependence.Subjects (N = 80) were randomized to gabapentin (600 mg three times per day or 900 mg three times per day) or placebo. After a 2-week dose titration, the target dose was maintained for 9 weeks and then tapered over 1 week. Follow-up was for 12 weeks after the medication phase.The study had high dropout rates with more than one half of participants in each arm discontinuing study. Gabapentin-treated participants exhibited lower abstinence rates than placebo-treated participants; however, this difference was not significant. Smoking reduction was observed across all treatment arms compared with baseline (p < .01) but did not differ across treatment groups.Although not definitive, our findings suggest that gabapentin administered at these doses with this dosing regimen holds little promise for the treatment of tobacco dependence in a population of smokers seeking treatment.

SUBMITTER: Sood A 

PROVIDER: S-EPMC2825098 | biostudies-literature | 2010 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Gabapentin for smoking cessation.

Sood Amit A   Ebbert Jon O JO   Wyatt Kirk D KD   Croghan Ivana T IT   Schroeder Darrell R DR   Sood Richa R   Hays J Taylor JT  

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20100115 3


<h4>Introduction</h4>We conducted a preliminary proof-of-concept study evaluating gabapentin for the treatment of tobacco dependence.<h4>Methods</h4>Subjects (N = 80) were randomized to gabapentin (600 mg three times per day or 900 mg three times per day) or placebo. After a 2-week dose titration, the target dose was maintained for 9 weeks and then tapered over 1 week. Follow-up was for 12 weeks after the medication phase.<h4>Results</h4>The study had high dropout rates with more than one half o  ...[more]

Similar Datasets

| PRJNA75689 | ENA
| phs000404.v1.p1 | EGA
2015-11-23 | GSE53519 | GEO
| S-EPMC3352787 | biostudies-other
| S-EPMC4645840 | biostudies-other
| S-EPMC3772534 | biostudies-literature
| S-EPMC6635501 | biostudies-literature
| S-EPMC7175455 | biostudies-literature
| S-EPMC6568235 | biostudies-literature
2012-09-01 | GSE18033 | GEO